pfizer glp-1 pipeline ADA '26: Lilly's dominance, Pfizer's 'foundational' drug and Roche's 'me-too' option Woke up to news that

Case 2: Seeing visceral fat directly on CT Another patient with CT-detected coronary atherosclerosis and a raised fat attenuation index (FAI) a marker of coronary inflammation showed a glucose profile on CGM very similar to the first case

This binding stimulates these cells to synthesize and secrete growth hormone

A 2019 systematic review of five placebo-controlled trials conducted by one group of investigators examined the effect of acetyl-L-carnitine (ALCAR) in 398 participants with cirrhosis and portal hypertension (high blood pressure in the portal vein) and presenting with either subclinical or overt hepatic encephalopathy

Shotsy 3.0, released in March 2026, introduced oral GLP-1 tracking for the Wegovy pill and other oral formulations, a first-of-its-kind Maintenance Mode for users who have reached their goal weight, and multi-medication scheduling for the growing number of people on combination regimens

What Does the Future Hold for Peptides and Joint Health